This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

"Medical Insights" Project From SAP To Accelerate Personalized Treatment For Cancer Patients

ORLANDO, Fla., Feb. 24, 2014 /PRNewswire/ -- To support patients in receiving the maximum benefit from every research and healthcare dollar spent, SAP AG (NYSE: SAP) is developing innovative solutions aimed at significantly improving health outcomes while cutting costs and improving outcomes at each step of healthcare delivery. Providing the latest example, the company today announced the first early, live deployment of the project "Medical Insights" for clinical data integration, an important advancement in cancer treatment. The announcement was made at HIMSS14, being held February 23-27 in Orlando, Florida.
SAP Logo

"The entire healthcare community recognizes the need to simplify and extract data for the benefit of individual patients," said Bill McDermott, co-CEO and member of the Executive Board of SAP AG. "With the 'Medical Insights' project, we're working on being able to unleash the power of the SAP HANA platform and apply this breakthrough to improving patient care. There is no question that real-time data and analytics will drive more personalized care and better outcomes throughout the healthcare system."

Almost every instance of cancer is unique. There is an immense volume and variety of information processed in providing care to those who have not responded to standard therapies, such as the analysis of multiple cohort studies, long-term studies following groups of people who have and do not have a given condition. Today, these tasks involve manually reviewing, parsing and consolidating the relevant information, typically in spreadsheets. These manual processes cause significant delays for patients waiting for care targeted at individual cancers.

With this project, SAP will aim to improve the accuracy of cancer diagnoses and, ultimately, patient outcomes by enabling integrated access to clinical information and analyzing complex data sets in real time. Built on the SAP HANA® platform, the project was developed in partnership with the German National Center for Tumor Diseases (NCT) and is now in use for testing purposes at its facilities in Heidelberg.

"We are now able to extract and analyze data from various sources and present it to physicians and researchers in a way that enables surprising new insights," said Professor Dr. Christof von Kalle, director, translational oncology, NCT. "In the future, we would like to use the SAP HANA platform for every diagnostic and therapeutic step, because every cancer is different and can vary immensely from one patient to the next."

"Medical Insights" is envisioned to use a generic healthcare data model and semantic capabilities to pull patient data from many different sources, such as clinical information systems, tumor registries, biobank systems and even text documents like a physician's notes. It will then run the advanced data analytics on the underlying SAP HANA platform and provide the results in real time. This is meant to help increase efficiency among various medical teams so that doctors have the most up-to-date information on their patients allowing for a faster, more accurate diagnosis. Patient cohorts are pictured to be posted and edited collaboratively, exported for further analysis in other software or compared according to different metrics.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs